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Abstract
Protein aggregation is sequence specific, favoring self-
assembly over cross-seeding with non-homologous
sequences. Still, as the majority of proteins in a
proteome are aggregation prone, the high level of
homogeneity of protein inclusions in vivo both during
recombinant overexpression and in disease remains
surprising. To investigate the selectivity of protein
aggregation in a proteomic context, we here compared
the selectivity of aggregation-determined interactions
with antibody binding. To that purpose, we synthesized
biotin-labeled peptides, corresponding to aggregation-
determining sequences of the bacterial protein β-
galactosidase and two human disease biomarkers:
C-reactive protein and prostate-specific antigen.
We analyzed the selectivity of their interactions in
Escherichia coli lysate, human serum and human
seminal plasma, respectively, using a Western blot-
like approach in which the aggregating peptides replace
the conventional antibody. We observed specific
peptide accumulation in the same bands detected by
antibody staining. Combined spectroscopic and muta-
genic studies confirmed accumulation resulted from
binding of the peptide on the identical sequence of the
immobilized target protein. Further, we analyzed the
sequence redundancy of aggregating sequences and
found that about 90% of them are unique within their
proteome. As a result, the combined specificity and lower Ltd. All rights reserved. J. Mol. Biol. (2015) 427, 236–247
237Aggregation-Determining Interactionssequence redundancy of aggregating sequences therefore contribute to the observed homogeneity of protein
aggregation in vivo. This suggests that these intrinsic proteomic properties naturally compartmentalize
aggregation events in sequence space. In the event of physiological stress, this might benefit the ability of cells
to respond to proteostatic stress by allowing chaperones to focus on specific aggregation events rather than
having to face systemic proteostatic failure.
© 2014 Elsevier Ltd. All rights reserved.Introduction
Protein aggregation of misfolded proteins is medi-
ated by self-association of short aggregation-prone
polypeptide segments into β-sheet assemblies [1–3].
The determining role of these interactions in aggre-
gation was demonstrated by grafting aggregation-
prone sequence of amyloid-forming proteins into
loop regions of non-aggregating proteins whereby
the aggregation tendency and amyloid morphology of
the originating protein were recapitulated [4,5]. The
interaction of these aggregation-prone sequences
appears to be highly sequence dependent and shows
a bias toward self-association over hetero-assembly
[6–8]. For instance, co-expression of aggregating
proteins with different sequences results in the
formation of separate inclusion bodies both in
Escherichia coli [9] and in mammalian cells [9].
Second, seeding of aggregation reactions, which is
measured by the disappearance of a nucleation-
dependent lag phase in the aggregation kinetics, is
generally only effective with identical or very similar
sequences [6,8]. The structure of several amyloid-
forming peptides has been solved, providing further
support for the sequence specificity of protein
aggregation [10–13]. These structures are character-
ized by a regular β-sheet structure in which side
chains are tightly packed both by registered stacking
of identical residues within a β-sheet and by into steric
zippers stabilizing β-sheet interfaces on top of each
other. Given the highly ordered in-register stacking of
identical side chains, incorporation of non-homologous
sequences will likely be sterically disfavored. In fact,
the specificity of aggregation appears to be sohigh that
simple point mutations can create transmission
barriers precluding prion propagation [14]. On the
other hand, it should be noted that the sequence
specificity of aggregation is not absolute. For instance,
evidence for cross-seeding between Aβ and α-
synuclein suggests that, in rare occasions, non-
identical sequences can co-aggregate [15]. This is
also the case of mutant p53 that co-aggregates
with its homologs p63 and p73 in human tumors
[7]. However, the aggregation-determining sequences
of p53 and its homologs are very similar, again
suggesting that aggregation is a sequence-specific
process. Conversely, the specificity of aggregation-
determining interactions can also be used to inhibit
aggregation [16,17]. Similarly, grafting the aggregation-
prone sequence of Aβ, α-synuclein or IAPP inplace of the complementarity-determining region
loop of a single domain antibody leads to the
specific binding of these antibodies to their respective
target protein thereby inhibiting its aggregation
[18].
In the light of these observations, the question
is therefore not whether aggregation-determining
interactions provide binding specificity but rather
to what extent these are able to segregate self-
association from cross-binding in a complex prote-
omic background consisting of hundreds and even
thousands of aggregation-prone sequences. Rather
than being characterized by a catastrophic proteo-
static collapse, aggregation-associated diseases
are on the contrary generally characterized by a
slow proteostatic erosion, sometimes over decades,
associated with specific disease-defining aggregating
proteins [19,20]. Can our current structural under-
standing of aggregation mechanisms account for this
observation or is this apparent specificity determined
primarily by biological context? Aggregation-prone
sequences are relatively short, ranging from approx-
imately 5–15 residues [21]. The specificity of these
sequences will therefore be determined by two
factors: the intrinsic specificity of their interactions
(i.e., their ability to segregate self from non-self) and
the redundancy of these short motifs in the proteome
in which they are expressed. In order to contribute to
the evaluation of these parameters, we here investi-
gated whether aggregation-determining interactions
can be exploited to detect proteins in complex media
using labeled peptides containing protein-specific
aggregation-determining sequences. To this purpose,
we selected three proteins: β-galactosidase (β-Gal)
from E. coli and two human biomarkers [C-reactive
protein (CRP) and prostate-specific antigen (PSA)
and designed biotin-labeled peptides consisting of
the aggregation-determining sequences of these
proteins]. We found that these aggregating peptides
specifically bind to their respective comprising proteins
using a peptide-based equivalent ofWestern blot (WB)
of denaturing gels of whole E. coli lysates, human
serum and human seminal plasma, respectively.
Moreover, sequence analysis of the aggregation-
determining proteome (or “aggregome”) of E. coli
and human revealed a low sequence redundancy
of aggregation-prone sequences. These findings
suggest that the observed specificity of protein
aggregation in vivo may be attributed to the short-
stretch interactions.
238 Aggregation-Determining InteractionsResultsDetection of β-Gal in E. coli lysates by protein
aggregation
To explore the interactions of aggregation-prone
sequences in denatured proteomes, we set up an
experimental platform referred to as PepBlot that
can be likened to an antibody-free version of WB
(Fig. 1a). In our assay, we substituted the usual
antibody as the specific primary probe with a labeled
peptide whose sequence corresponds to an
aggregation-prone segment of the target protein,
identified using TANGO [22], a statistical mechanics
algorithm for predicting aggregation-prone sequences.
In our design template, the probe peptide is composed
of the β-aggregating bait sequence flanked by
so-called gatekeeper residues [21,23] (usually
charged residues) that act as solubilizing moieties,
as well as a detectable molecular tag, such as biotin,Fig. 1. PepBlot design, specificity and sensitivity of β-Gal d
diagram illustrating the principles of PepBlot analysis for detec
The labeled probe peptides contain sequence matching the ag
protein. (b) Detection of β-Gal in E. coli BL21 AI lysates usin
peptides b ~ RVIIWSLGNR and b ~ RLAVVLQR and non-agg
β-Gal. (c) Effect of β-sheet disrupting mutations on the specifici
to-noise ratio comparison of the performance of wild-ty
(b ~ RVPIWSLGNR, b ~ RVIPWSLGNR and b ~ RVIPESLG
conditions and subject to same exposure conditions). (e) Se
spiked (0–1160 ng) in non-induced E. coli BL21 AI lysates. (f)
accumulation on the band corresponding to β-Gal in E. coli BL2
formulation buffer for 30 s to 1 h and stained with HRP conjuglinked to the N-terminus via a non-participating amino
acid linker, for which we employed the amino acid
sequence “APAA”.
Using this strategy, we first performed a PepBlot
assay of β-Gal (molecular mass ~ 116 kDa)
endogenously expressed in E. coli BL21 AI
cells. We identified two candidate sequences with
TANGO aggregation scores greater than 50 (out of a
maximumof 100) (Supplementary Fig. 1): L7AVVLQ12
and V453IIWSLGN460. Exhaustive sequence compar-
ison of these segments to the entire E. coli proteome
revealed that the sequencesVIIWSLGNand LAVVLQ
are unique to β-Gal. We designed N-terminally
biotinylated derivatives of the target sequences to be
used as primary peptide probes in the PepBlot assay
using Arg as gatekeeper residues (b ~ RVIIWSLGNR
and b ~ RLAVVLQR, where “b” stands for biotin).
Both b ~ RVIIWSLGNR and b ~ RLAVVLQR show
specific binding to a band corresponding to the
expected apparent molecular weight of β-Gal, which
is also recognized by anti-β-Gal polyclonal antibodyetection using sequence-specific peptides. (a) Schematic
ting protein biomarkers in corresponding native proteome.
gregation-prone segment (highlighted in red) of the target
g anti-β-Gal antibody and sequence-specific aggregating
regating off-target peptide b ~ RPITVNPPFR derived from
ty of peptide b ~ RVIIWSLGNR to detect β-Gal. (d) Signal-
pe peptide, b ~ RVIIWSLGNR and mutant peptides
NR) to detect β-Gal (the blots were treated under identical
nsitivity of the peptide b ~ RVIIWSLGNR to detect β-Gal
Time-dependent kinetics of the peptide b ~ RVIIWSLGNR
1 AI lysates. Themembranes were incubated in the peptide
ated to streptavidin.
239Aggregation-Determining Interactions(Fig. 1b). The signal-to-noise ratio obtained with the
former peptide is significantly higher and is compara-
ble to antibody detection (Supplementary Fig. 2). In
order to probe the specificity of interaction of the probe
peptide, we performed detection experiments using
additional peptides. First, we probed β-Gal with an
off-target non-aggregating but hydrophobic β-Gal
peptide (P106ITVNPPF113), and found no interaction
of the correspondingprobepeptideb ~ RPITVNPPFR
with β-Gal (Fig. 1b and Supplementary Fig. 1).
Second, we employed four probe peptides whose
sequences correspond to aggregating regions identi-
fied using TANGO in unrelated bacterial and human
proteins. All of these peptides failed to yield specific
staining of the band corresponding to β-Gal
(Supplementary Fig. 3) showing that aggregation
propensity is necessary but not sufficient for specific
interaction. Finally, we introduced point mutations
in the b ~ RVIIWSLGNR probe peptide to modulate
its aggregation propensity while preserving a high
sequence identity. Pro, which lowers aggregation
propensity by breaking β-strand structure [24], was
substituted for both Ile residues individually (yielding
b ~ RVPIWSLGNR and b ~ RVIPWSLGNR) and the
latter was also combined with a Trp-to-Glu mutation
(yielding b ~ RVIPESLGNR), which suppresses
aggregation, by the introduction of a repulsive charge.
The PepBlot assay of the two single point mutants
b ~ RVPIWSLGNR and b ~ RVIPWSLGNR still
showed binding to β-Gal but displays significant
loss of specificity as several off-target bands
become apparent with low signal-to-noise ratio
(Fig. 1c andd). Furthermore, thedoublemutant peptide
b ~ RVIPESLGNR displayed an almost complete loss
of interaction. This demonstrates that a single point
mutation is sufficient to suppress binding specificity of
this aggregation-prone peptide and that suppression
of the aggregation propensity using two mutations is
sufficient to abolish binding altogether despite 80%
sequence identity. These data confirm our hypothesis
that aggregation propensity and sequence matching
are a prerequisite for the specificity of peptidemediated
interaction and are in line with a recent study showing
that scrambled or reversed versions of the islet amyloid
polypeptide do not cross-seed with each other or the
wild-type sequence, confirming position dependence
beyond mere sequence composition [8].
In order to evaluate the detection limit of β-Gal by
b ~ RVIIWSLGNR in the PepBlot assay, we titrated
recombinant β-Gal in the concentration range 11.6–
1160 ng to a complete non-induced E. coli BL21 AI
cell lysate. The b ~ RVIIWSLGNR peptide could
detect as little as 58 ng of β-Gal, which is comparable
to the detection limit of an antibody (Fig. 1e and
Supplementary Fig. 4). Interestingly, exposing the
membrane to the probe peptide for 30 s was sufficient
to achieve β-Gal detection (Fig. 1f). On prolonged
incubation, no significant improvement in signal
density was observed, although the specific bindingof the streptavidin (low-molecular-mass band) dimin-
ished over time.
In order to confirm these results in an independent
experimental setup similar to the PepBlot experiment,
we measured peptide interaction with β-Gal using
surface plasmon resonance (SPR). β-Gal was
covalently immobilized via amine coupling on the
surface of a CM5 sensor chip and binding response
curves of 1 μM of the β-Gal-derived peptides (His)6 ~
RVIIWSLGNR, (His)6 ~ RLAVVLQR and (His)6 ~
RPITVNPPFR were recorded at 25 °C (the polyhisti-
dine tag enhanced the solubility of the peptides
rendering the peptide handling more feasible in this
setup). As a background control, we immobilized an
equal amount of bovine serum albumin (BSA) in the
reference channel. The results (Fig. 2a) are in good
agreement with those in the PepBlot assay. Both
non-aggregating peptide (His)6 ~ RPITVNPPFR and
the (His)6 ~ RLAVVLQRpeptide showonly veryweak
binding, whereas the peptide (His)6 ~ RVIIWSLGNR,
whose performance was in par with antibody in the
PepBlot assay, shows a strong signal in SPR. Similar
results were obtained with the peptides carrying
aggregation-reducing mutations: we observed a
6-fold decrease in SPR response with the single Pro
mutations ((His)6 ~ RVPIWSLGNR and (His)6 ~
RVIPWSLGNR),which further decreased to the buffer
baseline when the analyte was the double mutant
((His)6 ~ RVIPESLGNR) (Fig. 2b), again demonstrat-
ed the sequence specificity of peptide binding. Using
the SPR data, we analyzed the kinetics of (His)6 ~
RVIIWSLGNR peptide deposition on the immobilized
β-Gal protein (Fig. 2c) and found that it was best
described by a multi-step kinetic mechanism similar
to that proposed for Aβ peptide aggregation [25]. In
this so-called “dock-and-lock” scheme, a fast initial
encounter is followed by slower conformational
rearrangements that lock the perfused peptide on
the β-aggregate-prone sequence of β-Gal (Supple-
mentary Table 1). Together, these data confirm
the hypothesis of a sequence-specific aggregation
mechanism of probe binding to β-Gal.
Given limitations for the biophysical characteriza-
tion of peptide and protein aggregates upon surface
immobilization, we investigated peptide-induced
aggregation of purified recombinant β-Gal in solution
using turbidity, dynamic light scattering (DLS),
circular dichroism (CD) and Fourier transform
infrared (FTIR) spectroscopy. We monitored aggre-
gation following turbidity at 340 nm for 2 h of a
solution of 10 μM β-Gal in the presence of increasing
amounts of the peptide (His)6 ~ RVIIWSLGNR,
ranging from substoichiometric to equimolar ratios.
At the start and end points of the assay, DLS
data were recorded to estimate the hydrodynamic
radius (RH) of the resulting aggregates. Whereas
β-Gal on its own shows negligible aggregation
during the time of this experiment, addition of even
substoichiometric peptide concentration leads to an
Fig. 2. Mechanisms of the peptide mediated β-Gal aggregation. (a) Double-reference-subtracted SPR sensorgrams of
β-Gal-derived aggregating peptides (His)6 ~ RVIIWSLGNR and (His)6 ~ RLAVVLQR and non-aggregating off-target
peptide (His)6 ~ RPITVNPPFR injected over β-Gal covalently immobilized on the surface of a CM5 sensor chip.
(b) Comparison of SPR sensorgrams of the wild-type peptide (His)6 ~ RVIIWSLGNR versus β-sheet disrupting mutant
peptides co-aggregating with immobilized β-Gal. (c) Kinetic analysis of the interaction of the peptide (His)6 ~ RVIIWSLGNR
(0–4 μM)with immobilized β-Gal. The broken line represents a global fit to a three-state “dock-and-lock”mechanism similar to
the previously describedmechanism of Aβ peptide fibrillation [15]. (d) Peptide (His)6 ~ RVIIWSLGNR seeded aggregation of
10 μM β-Gal solution. The aggregate growth was monitored by light scattering in the presence of increasing amount of the
peptide (His)6 ~ RVIIWSLGNR: 2 μM (red triangle), 5 μM (green square) and 10 μM (yellow diamond); the control β-Gal
solution without peptide is shown in black circle. The arrow indicates average hydrodynamic radius (RH), respectively, of the
soluble andaggregated peptide–protein at the start and end of the reaction. (e) CDspectra and (f) FTIR spectra of nativeβ-Gal
solution and isolated peptide (His)6 ~ RVIIWSLGNR-β-Gal co-aggregate suspension after 2 h reaction.
240 Aggregation-Determining Interactionsimmediate increase in turbidity with a lag phase that
reduced to below 10 min (first measurement),
consistent with seeded aggregation (Fig. 2d). DLS
confirms the formation of fairly large aggregates
and as expected the different ratios of seed peptide to
protein produce different size regimes. To determine
whether the peptide (His)6 ~ RVIIWSLGNRmediatesco-aggregation of the protein through intermolecular
β-sheet assembly and provide a mechanistic frame-
work for the short-stretch interaction, we characterized
the structure of the peptide–protein co-aggregates
isolated from solution. CD analysis of the aggregate
suspension shows a negative band ~218 nm charac-
teristic of aggregated β-sheets (Fig. 2e). Also, FTIR
241Aggregation-Determining Interactionsspectra of the aggregates report an amide I band at
1628 cm−1 due to β-sheets displaying a shift from
1638 cm−1 observed for folded β-Gal (Fig. 2f).
Electron micrograph imaging of the aggregates
shows an amorphous aggregate morphology that is
found by SDS-PAGE to be enriched with β-Gal
(Supplementary Fig. 5 and Supplementary Fig. 6).
To confirm the sequence specificity in this experimen-
tal setup, we assayed the ability of themutant peptides
to mediate co-aggregation of β-Gal in solution. We
observed a marked reduction of the turbidity increase
in the presence of the single mutants ((His)6 ~
RVPIWSLGNR and (His)6 ~ RVIPWSLGNR)
(Supplementary Fig. 7), and consistently, the trace in
the presence of the double mutant peptide ((His)6 ~
RVIPESLGNR) approaches that of the control β-Gal
aggregation measured in the absence of peptides.
Together, these data confirm that the interaction
between peptide (His)6 ~ RVIIWSLGNR and β-Gal
induces aggregation by formation of intermolecular
β-sheet structure and that the sequence specificity of
this mechanism allows protein detection by target-
specific aggregating peptides.
Detection of CRP and PSA in human samples
To explore whether the PepBlot approach could
also be applied to proteomes of other origin, compo-
sition and complexity than E. coli lysate, we designed
a PepBlot assays to detect protein biomarkers CRPFig. 3. PepBlot analysis of CRP in clinical serum and PS
samples of 20 patients using the peptide b ~ RILIFWSR (
determined by immunoturbidimetric assay was in the range 1
signal density detected by the peptide b ~ RILIFWSR ve
immunoturbidimetric assay at a clinical laboratory. (b) Detect
peptides b ~ RWQVLASD (lane 2) and b ~ RQWVLTAAR (lan
the C-terminal sequence of PSA is shown in lane 1.in human blood serum and PSA in seminal plasma.
CRP is a widely used biomarker for inflammation [26],
which gave us an abundant source of clinical serum
samples for which CRP determinations based on
independent immunoturbidimetric assay were avail-
able. Based on TANGO prediction, we generated
peptides targeting the sequence A32FTVCLHFYT41
and I63LIFWS68 (Supplementary Fig. 8). For CRP
detection in serum, the probe peptide b ~ RILIFWSR,
which is unique to CRP, was selected based on the
performance in initial trails (SupplementaryFig. 9).We
then proceeded to evaluate the specificity of our probe
peptide to detect CRP in clinical serum samples.
Accordingly, 20 blood serum samples of patientswere
processed and the presence of CRP was detected
using PepBlot, which revealed specific staining to a
well-defined band corresponding to the molecular
weight of CRP (Fig. 3a). The quantification of the
intensity of these bands compares well with the data
obtained from the standard clinical immunoturbidi-
metric assay as performed independently on the
same samples. Finally, we designed a PepBlot assay
for detection of PSA, a member of the tissue kallikrein
family of proteases that is synthesized in prostate
gland, secreted in seminal fluid and is used as a
biomarker for prostate cancer [27]. We synthesized
peptides targeting the sequence W14QVLVAS20 and
the sequence Q34WVLTAA40 that were predicted by
TANGO (Supplementary Fig. 10). The corresponding
peptides (b ~ RWQVLASD and b ~ RQWVLTAAR)A in seminal plasma. (a) CRP detection in clinical serum
top panel). The concentration of CRP in clinical serum
–317 μg ml−1. Bottom panel shows the plot of CRP band
rsus concentration determined independently with an
ion of PSA secreted in human seminal plasma using the
e 3). TheWB of monoclonal antibody (EP1588Y) specific to
242 Aggregation-Determining Interactionsaccumulated on a protein band at an apparent
molecular mass of approximate 30 kDa that was
identified by a monoclonal antibody to be specific to
the C-terminal sequence of PSA (Fig. 3b). As a further
confirmation, weperformed trypsin digestion andmass
spectrometry analysis as N-terminal sequencing,
which confirm PSA as the main component of the
band (Supplementary Table 2).
Aggregation-prone sequences display low
proteomic redundancy
In order to evaluate the redundancy of aggregation-
prone sequences within their proteomes, we
employed TANGO to determine all APRs in proteome
assemblies of E. coli, Saccharomyces cerevisiae and
Homo sapiens (with an average TANGO cutoff over
the window large than 5). The distribution of the length
of these APRs (Fig. 4a) and the TANGO score
(Fig. 4b, ranging between 0 and 100) of the regions
identified are very similar in the different proteomes.
The number of APRs occurring in any proteome
declines with APR length following a powerlaw
distribution. The distribution of TANGO score follows
a more complex distribution, but the main peak is
toward the lower scores. We analyzed the fraction of
APR sequences that are unique within their proteome
as a function of their length (Fig. 4c), which revealed
that more than 80% of the APRs occurs only once
within their proteome, although the exact figure
depends somewhat on proteome size. Since we
wondered if this feature is specific to aggregation-
prone sequences or if it holds more generally for all
amino acid sequences, we generated three sets of
randomly selected sequences from E. coli that score
zero with TANGO but have an identical size and
length distribution as the APR set from this species.
We then compared the redundancy profiles of the
non-aggregating sequence fragments and the APRs
(Fig. 4d): both follow a similar profile, although the
non-aggregating sequences are slightly more
frequently unique than APRs, probably owing to the
decreased sequence complexity of APRs due to the
virtual absence of charged andpolar amino acids. The
size of 7–8 amino acids seems to be a point at which
sequences are mostly unique, which is incidentally a
frequently occurring size in the database of more than
180,000 linear antibody epitope sequences (Fig. 4a,
inset), suggesting that this length is sufficient to
specifically recognize a particular protein in a complex
proteome. In addition,wealso investigated the number
of identical matches found for each APR within the
E. coli proteome (Fig. 4e). These data reveal that, for
most sequences that are not unique, the number of
copies in the proteome is two or three at most.
Finally, for the specific peptides we employed, we
analyzed not only their uniqueness but also the
frequency of occurrence of sequences that differ by
only one or two mutations (Fig. 4f–h). These datashow a significant number of sequences that are one
mutation removed from the target and an even larger
number with two mutations. In view of our PepBlot
results shown above, this suggests strong selectivity
in the APR mediated interactions.Discussion
Our results show that target-specific aggregating
peptides of β-Gal in E. coli and two human
biomarkers CRP and PSA can be used to selectively
detect these target proteins on a WB of denatured
E. coli lysates, human serum and human seminal
plasma, respectively. In particular, we show these
peptides to accumulate in the same bands detected
by conventional antibody staining and that binding
results from aggregation-determining interaction.
This particular experimental setup for protein detec-
tion was chosen for several reasons. First, detection
on a WB of denatured SDS-PAGE gels avoids
technical difficulties of measuring specific peptide–
protein co-aggregation in solution and facilitates
comparing target detection by biotinylated peptides
with antibody detection by a monoclonal antibody
against the same target. Second, this experimental
configuration ensures that the denatured proteome
is displayed so that buried aggregation-prone
sequences are more likely to be exposed. This not
only should maximize the opportunity of peptides to
bind their target sequence but also provides ideal
conditions to test potential off-target binding as all
other proteins will likewise expose their aggregation-
prone sequences. In a simplified manner, this could
be likened to a situation mimicking the exposure of
aggregating sequences during cellular stress [28].
Nevertheless, even under these extremely denatur-
ing conditions, we find that the interactions clustering
proteins into aggregates are sufficiently specific to
allow selective binding of aggregation-prone pep-
tides to their homologous endogenous counterpart
thereby discriminating a background of hundreds of
different aggregation-prone regions (APRs).
In order to assess the role of sequence redundancy
in aggregation, we also performed a bioinformatics
analysis of the diversity of aggregating sequences in
several proteomes. We find that the degree of
sequence redundancy of these sequences is gener-
ally low although most proteins possess aggregation-
prone sequences. Our findings therefore suggest that
the combined specificity of aggregation-dependent
self-assembly and the low redundancy of these
sequences contributes to the homogeneity of protein
aggregation. However, this does not preclude other
biological and biophysical factors to also contribute:
protein stability, localization and temporal or spatial
expression patterns of the proteome will further
determine the observed specificity of aggregation
in vivo.
243Aggregation-Determining InteractionsThe finding that both the intrinsic aggregation
specificity and low sequence redundancy of aggre-
gating sequences contributes to the isolation of
aggregation-determined interactions in a proteomic
context could have important implications for the ability
of cells to survive situations of cellular stress. As most
proteins posses aggregation-prone sequences, stress
will result in an increased aggregation propensity of the
entire proteome, requiring appropriate proteostatic
responses such as HSF-1 upregulation [29]. However,
as the proteostatic machinery has a limited capacity
[30–32], aggregation is still likely to occur under
situations of enduring stress [33]. In a scenario by
which aggregation is unspecific, the aggregation of any
given protein would result in the seeding of many other
proteins with different sequences, thereby inducing
an aggregation cascade leading to a generalized
proteostatic collapse. However, under a scenario of
sequence-determined isolation of aggregation further
amplified by biological context, aggregation of one
protein will be much less likely to spread to other
proteins. This would minimize the risk for irreversible
proteostatic collapse as individual proteins can be
stored in homogenous inclusion bodies to be removed
by protein degradation after physiological conditions
have returned to normal. This could also possibly
contribute to the slow evolution of aggregation-associ-
ated disease where chronic protein accumulation lasts
for several years or decades before tissue degradation
becomes apparent. Although these possibilities remain
to be investigated in vivo, the current study provides a
rational basis to test these hypotheses in vivo.
It will also be interesting to further analyze whether
selective pressure against co-aggregation has played
a purifying role on the sequence composition of
proteomes, especially given the role of gene duplica-
tion in evolution. Finally, our results suggest thatAPRs
could be used as barcodes as an alternative method
for protein detection and identification.Materials and Methods
Peptide design and synthesis
The β-aggregation-prone sequences of mature β-Gal,
CRP and PSA were identified using TANGO [10], a
statistical mechanical algorithm for predicting β-aggregation
propensity of polypeptides and proteins. The criteria for
selecting the target sequence were as follows: (a) The
peptide stretches should have at least five successive
residues with a TANGO score of N5 per residue and (b) the
total score of the selected windows should exceed N50,
indicating highly APRs.
Libraries of probe peptides carrying bait sequences
corresponding to predicted aggregation-prone stretches of
the target proteins flanked by charged gatekeeper residues
were synthesized (N90% purity) using the PepSpot tech-
nology (JPT Peptide Technologies GmbH). The C-termini ofthese peptides were acetylated and linked to biotin (“b”) or
polyhistidine (His)6 tags via an N-terminal “~APAA~” linker.
Expression of β-Gal
Full-length β-Gal was expressed in competent E. coli
BL21 AI cells. Bacteria carrying the expression construct
pBad_betagal_WT were cultured in lysogeny broth
medium at 37 °C. When an OD600 nm of the culture
reached ~0.6, the cells were induced with 0.2% arabinose
and allowed to grow overnight at 37 °C. In parallel,
competent E. coli BL21 AI cells that did not express
β-Gal were grown for control and titration experiments.
E. coli BL21 AI cells were lysed at room temperature
with bacterial protein extraction reagent (B-PER, Thermo
Scientific) containing protease inhibitor. Whole cell lysate
was mixed with 5× SDS protein loading buffer (Fermentas)
and heated at 99 °C for 3 min and then fractionated by
SDS-PAGE using 10-well NuPage 4–12% Bis-Tris gels
(Invitrogen) in 4-morpholineethanesulfonic acid (Mes)–
SDS running buffer (0.1% SDS, 50 mM Mes and 50 mM
Tris–base). The separated proteins were transferred to
nitrocellulose membrane and blocked overnight with 1%
BSA in phosphate-buffered saline and 0.05% Tween 20,
pH 7.4 (PBS-T) at 4 °C. Each lane of the membrane was
cut out and separately incubated, as detailed below, with
rabbit polyclonal anti-β-Gal antibody (Sigma), on-target
peptides b ~ RVIIWSLGNR or b ~ RLAVVLQR, off-target
peptide b ~ RPITVNPPFR or biotinylated mutant variants
of the peptide b ~ RVIIWSLGNR.
β-Gal WB
To detect β-Gal expressed in E. coli BL21 AI cells, we
cut out one lane of the membrane and incubated it in
PBS-T with rabbit polyclonal anti-β-Gal antibody (1:1000)
under gentle agitation. After 1 h, the membrane was rinsed
with PBS-T, stained with goat polyclonal anti-rabbit antibody
conjugated to horseradish peroxidase (HRP) (Promega) for
1 h and then exposed to ECL reagent (SuperSignal West
femto maximum sensitivity substrate; Thermo Fisher Scien-
tific) and protein was visualized using Bio-Rad ChemiDoc
XRS imaging system.β-Gal PepBlot analysis
The procedure for PepBlot analysis of β-Gal in complete
cell lysate ofE. coliBL21AI usingbiotinylatedpeptideswasas
follows: Stock solutions (10 μM) of each of the biotinylated
pept ides (b ~ RVI IWSLGNR, b ~ RLAVVLQR,
b ~ RPITVNPPFR,b ~ RVPIWSLGNR,b ~ RVIPWSLGNR
and b ~ RVIPESLGNR) were prepared separately in 100%
DMSO. Peptides were diluted (1/40) in formulation buffer
(10 mMMes, 100 mM trehalose, 0.02% Tween 20, pH 5.5)
and gently agitated with the membranes at 25 °C for 1 h.
After four rinses in 10 mMMesand 0.02%Tween20, pH 5.5
buffer, themembranes were stained in PBS-T with the biotin
affinity reagent streptavidin conjugated to HRP (Abcam).
Each PepBlot was detected under identical condition using
femto-sensitive substrate and exposure time of 100 s.
To study the kinetics of the interaction between the
peptide b ~ RVIIWSLGNR and β-Gal (i.e., the contact time
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245Aggregation-Determining Interactionsbetweenprobepeptide and target protein) in the background
of complete E. coli BL21 AI cell lysate, we incubated
membranes in peptide formulation [250 nM peptide in
10 mM Mes, 100 mM trehalose, 0.02% Tween 20 (pH 5.5)
and 2.5% DMSO] from 30 s to 1 h. The membranes were
removed from the formulation buffer at different time points
(30 s, 5 min, 10 min, 15 min, 30 min, 45 min and 1 h), rinsed
in 10 mM Mes and 0.02% Tween 20 (pH 5.5) and further
processedasdescribedabove.Amembrane laneunexposed
to the peptide formulation was used as a negative control.
The detection sensitivity of the peptideb ~ RVIIWSLGNR
in PepBlot analysis was investigated by spiking complete
non-induced E. coli BL21 AI cells (OD600 nm ~0.6) with
recombinant β-Gal (Roche Diagnostics) in a concentration
range of 11.6–1160 ng. Whole non-induced E. coli BL21 AI
cell lysate containing spiked β-Gal was separated and
processed as described herein before.SPR experiments
The affinity of the peptides to co-aggregate with β-Gal was
measured by means of SPR at 25 °C using a Biacore T100
equipped with a CM5 sensor chip (GE Healthcare). Coupling
reagents [N-ethyl-N′-(3-dimethylaminopropyl)carbodiimide,
N-hydroxysuccinimide and ethanolamine HCl] were pur-
chased from GE Healthcare. The proteins BSA (Sigma) and
β-Gal (Roche Diagnostics) were immobilized in the reference
and sample channels, respectively, by standard amine
coupling chemistry at a flow of 10 μl min−1. The carbox-
ymethyl dextran surface was activated by injection of a 1:1
ratio of N-ethyl-N′-(3-dimethylaminopropyl)carbodiimide and
N-hydroxysuccinimide for 7 min. The proteins were diluted in
10 mMsodiumacetate buffer (pH 4.5) to a final concentration
of 0.2 mg ml−1 and injected in short pulses over the activated
surface until the immobilization levels reached 4000 RU or
8000 RU, for BSA and β-Gal, respectively. The remaining
reactive groups were blocked with 1 M ethanolamine, pH 8.
After completion of coupling, the surface was regenerated
with short pulses of 50 mM NaOH and 8 M urea to remove
non-covalently attached proteins. The immobilization levels
after the regeneration were typically between 3500 RU and
4000 RU in both reference and sample channels.
Thepeptides (His)6 ~ RVIIWSLGNR, (His)6 ~RLAVVLQR,
(His)6 ~ RPITVNPPFR, (His)6 ~RVPIWSLGNR, (His)6 ~
RVIPWSLGNR and (His)6 ~RVIPESLGNR were injected
over the reference (BSA) and sample (β-Gal) surfaces at a
concentration of 1 μM in running buffer (10 mM sodium
phosphate, pH 6.8, 150 mM NaCl, 3 mM ethylenediamine-
tetraacetic acid and 0.015% Tween 20). The injection time
was 60 s at a flow rate of 30 μl min−1 and was followed by a
600-sdissociation phase. The injectionswere repeatedon the
same surface and on independently immobilized surfaces.
Between each cycle, the surface was regenerated by 30 s
pulses of (i) 50 mM NaOH and (ii) 8 M urea and was allowedFig. 4. Analysis of redundancy of short sequence fragments
identified by TANGO in E. coli, S. cerevisiae and H. sapiens. (b
of the same APRs that is unique within its proteome plotted b
three random selections of non-aggregating sequence fragm
strength. (e) Distribution of the number of identical matches p
and with one or two mutations) of the β-Gal-derived peptide
CRP-derived peptide within the H. sapiens proteome. (h) Nu
H. sapiens proteome.to stabilize for 400 s before the next cycle. All sensorgrams
were double reference subtracted by (i) subtraction of the
response observed on the reference surface from the
response observed on the sample surface and (ii) subtraction
of the responses observed for buffer injections, the latter in
order to remove systematic artifacts.
The kinetics of the co-aggregation of β-Gal and wild-type
peptide (His)6 ~ RVIIWSLGNR was investigated by per-
fusing a range of peptide concentrations (0.5–4 μM, with
one internal replicate) over the immobilized reference and
sample surfaces. The concentration series was repeated
on the same surface (three times) and on independently
immobilized surfaces. The surface regeneration and
stabilization were as detailed above. Data were double
reference subtracted and fitted, using the Biacore T100
evaluation program, to a three-step conformational change
model assuming that an initial fast docking step (charac-
terized by association and dissociation rate constants, k1
and k−1, respectively), between the peptide in solution and
the immobilized peptide stretch on the surface, is followed
by two conformational changes resulting in a new,
identical, binding site where the aggregation reaction can
proceed. For a more detailed description on the kinetic
model, please refer to Cannon et al. [25].Light scattering
The co-aggregation of the wild-type peptide (His)6 ~
RVI IWSLGNR and mutant pept ides ( (His) 6 ~
RVPIWSLGNR, (His)6 ~ RVIPWSLGNR and (His)6 ~
RVIPESLGNR) with β-Gal were monitored in vitro via
light scattering by following the apparent change in the
OD340 nm at 25 °C. The aggregation was initiated by
adding equimolar molar (10 μM) concentration of the
peptides and β-Gal dissolved in 20 mM phosphate buffer,
pH 6.8, by gently stirring the mixture at 50 rpm. To
evaluate the limiting concentration required of the peptide
(His)6 ~ RVIIWSLGNR to induce protein aggregation, we
prepared a series of samples with β-Gal to peptide molar
ratios of 1:0, 1:0.2, 1:0.5 and 1:1 in 20 mM phosphate
buffer, pH 6.8. The concentration of β-Gal was 10 μM
while that of the peptide was 2 μM, 5 μM and 10 μM. The
hydrodynamic radius (RH) of the peptide (His)6 ~
RVIIWSLGNR-β-Gal mixture at time zero and after
co-aggregation for 2 h was measured using DynaPro
DLS (Wyatt Technology Europe, Germany).CD
The insoluble co-aggregate of the peptide (His)6 ~
RVIIWSLGNR and β-Gal were isolated after 2 h reaction
and washed with 20 mM phosphate buffer, pH 6.8, to
remove soluble peptide and protein. The isolated precipitate
was suspended in buffer and far-UV CD spectra werewithin their proteome. (a) Length distribution of the APRs
) TANGO score distribution of the same APRs. (c) Fraction
y length. (d) Fraction uniqueness versus length plotted for
ents from E.coli compared to APRs sorted by TANGO
er APR length in E. coli. (f) Number of matches (identical
s in the E. coli proteome. (g) Number of matches of the
mber of matches of the PSA-derived peptides within the
246 Aggregation-Determining Interactionsmeasured using a Jasco J-715 spectropolarimeter equipped
with a rotating sample cell holder [34]. Spectra of the sample
loaded in a 0.01-cm cylindrical quartz cell (Hellma Optics)
were acquired at 50 nm min−1 scan speed, 1 nm bandwidth
and 0.5 s time constant. All the spectra were reference
corrected and normalized to mean residual weight units.
Fourier transform infrared spectroscopy
The FTIR spectra of soluble native β-Gal and aggregate
suspensions were measured with a Bruker Tensor 27
infrared spectrometer equipped with BioATRCell II optics.
A 50-μl β-Gal or aggregate suspensions were loaded onto
the optical sample surface and 256 interferograms at a
resolution of 4 cm−1 were acquired, averagedandsmoothed.CRP detection in human serum
Blood samples of 20 patients (Universiteit Ziekenhuis,
Leuven) were processed according to standard protocol
and serum was separated to analyze CRP with standard
laboratory diagnostics employing an immunoturbidimetry
assay and PepBlot. The concentration of CRP was
measured by an immunoturbidimetry-based method
using latex particles coupled to monoclonal mouse anti-
CRP antibody. The test was performed on a Hitachi/Roche
Modular P system (Roche Diagnostics).
For PepBlot detection, a 7% dilute serum sample was
mixed with 5× SDS, heated at 82 °C for 5 min and
electrophoresed on 4–12% Bis-Tris gels; transferred to
polyvinylidene fluoride membranes and blocked with 1%
BSA. Themembraneswere agitated separatelywith 250 nM
peptideb ~ RAFTVCLHFYTR or b ~ RILIFWSR formulated
in 10 mM Mes buffer, pH 5.1, 100 mM trehalose, 0.05%
Tween 20 and 2.5% DMSO at 25 °C for 1 h. After rinsing
with 10 mM Mes buffer, pH 5.1, and 0.05% Tween 20, the
membranes were stained with HRP-streptavidin conjugate
and visualized with ECL system under identical conditions.PSA detection in human seminal plasma
Semen from amale volunteer was collected and allowed
to liquefy at room temperature. After 2 h, the seminal fluid
was centrifuged at 10,000g for 15 min to separate the
plasma from sperm cells. A sample of 10% seminal plasma
was fractionated under non-reducing condition using
denaturing gel electrophoresis and then transferred to
polyvinylidene fluoride membrane and blocked using
protocol described for serum electrophoresis. Lanes of
membrane were agitated separately with 250 nM peptide
b ~ RWQVLASD or peptide b ~ RQWVLTAAR formulated
in 10 mM Mes buffer, pH 5.1, 100 mM trehalose, 0.05%
Tween 20 and 2.5% DMSO at 25 °C for 1 h. The
membranes were rinsed in 10 mM Mes buffer, pH 5.1, and
0.05% Tween 20 and were stained with HRP-conjugated
streptavidin and visualized with ECL system. In parallel, WB
detection of PSA in seminal plasma was carried out by
incubating the membrane with (1:5000) rabbit monoclonal
anti-PSA antibody (EP1588Y; Abcam) specific to the
C-terminal peptide of PSA. This was followed by staining
with goat polyclonal anti-rabbit antibody conjugated to HRP
and visualized using ECL system.Computational analysis
All APR predictions were carried out using the standalone
version of the TANGO algorithm [22], using the standard
settings. Proteome builds were obtained from UniProt [35].Acknowledgements
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